Biophysics Seminar

GC4419 is a normal tissue radioprotector that also enhances the anti-tumor effects of high dose per fraction radiation and immune therapy

by Dr. Michael Dean Story (Radiation Oncology, Graduate School of Medical Sciences, UT Southwestern Dallas, USA), Dr. Anthony J. Davis (Radiation Oncology, Graduate School of Medical Sciences, UT Southwestern Dallas, USA)

Tuesday, March 5, 2019 from to (Europe/Berlin)
at GSI Helmholtzzentrum für Schwerionenforschung GmbH ( Lecture hall, Theory SB3 3.170a )
Planckstraße 1, 64291 Darmstadt, Germany
Material:
Organised by Prof. Dr. Marco Durante